Receive consulting resources in your inbox

RoundTable Healthcare Partners: Investment Strategy, Funds, Portfolio Companies, and Firm Profile

1. What Is RoundTable Healthcare Partners?

RoundTable Healthcare Partners is a healthcare-focused private equity firm founded in 2001 and headquartered in Lake Forest, Illinois. Its four founding partners were Joseph F. Damico, Lester B. Knight, Jack L. McGinley, and Todd E. Warnock. The organization combines healthcare operating experience with investment and transaction capabilities, rather than presenting itself as a generalist investment manager. Its investment history encompasses medical products and devices, pharmaceuticals, consumer health businesses, and related manufacturing and outsourced services.

For this directory, RoundTable is best classified as sector-specialist private equity within the supplied direct private equity and buyouts segment. Its documented transactions include majority investments and a minority investment in Designs for Health. North America is the appropriate editorial geography group, with the reviewed transaction examples concentrated in the United States. These classifications describe its investment model and observed activities; they do not constitute a performance assessment or verified ranking.

2. RoundTable Healthcare Partners at a Glance

Firm name
RoundTable Healthcare Partners
Firm type
Operating-oriented, healthcare-focused private equity firm
Founded
2001
Founders
Joseph F. Damico, Lester B. Knight, Jack L. McGinley, and Todd E. Warnock
Headquarters
Lake Forest, Illinois, United States
Parent organization
No parent organization verified
Main investment markets
North America, with United States-centered transaction examples in the reviewed portfolio
Geography group
North America
Directory segments
Direct private equity and buyouts; sector-specialist private equity
Principal strategies
Healthcare platform acquisitions, acquisition-led development, corporate carve-outs, and selected minority equity partnerships
Ownership approach
Documented majority and minority investments, including partnerships with continuing owners and management teams
Typical company profile
Established healthcare businesses with opportunities for operational development and growth
Sector focus
Medical products and devices; pharmaceuticals; consumer health; related manufacturing and outsourced services
Current major funds
Equity Fund VI is the latest verified equity fund final close; Fund V is identified in reviewed original investment disclosures
Current status
Operating, with investment and operating-team announcements during 2026
Official website
RoundTable Healthcare Partners Official Website

The fund and strategy descriptions distinguish the investment firm from its individual equity and subordinated debt vehicles. Current numerical company-size criteria and a complete management-company ownership breakdown have not been verified.

3. Who Founded RoundTable Healthcare Partners, and How Is the Firm Organized?

RoundTable’s founding team combined corporate healthcare leadership and healthcare investment banking. Lester B. Knight had been chairman and chief executive officer of Allegiance Corporation, while Joseph F. Damico had been its president and chief operating officer. Jack L. McGinley brought senior operating experience from Baxter International. Todd E. Warnock had led United States healthcare investment banking at Credit Suisse First Boston. These were individual founding partners, not institutions described as owners of the firm.

The business began in 2001. Its launch-era disclosures identify Lake Forest as its base by the first fund’s March 2002 closing; a distinct earlier founding address has not been established. Institutional investors in the debut fund included endowments, pension funds, financial institutions, fund managers, and foundations. Their participation as limited partners should not be confused with founding or controlling the management organization.

The present organization separates transaction work, operating capabilities, and administration. Barbara Sullivan and Thomas P. Kapfer are identified as co-chairpersons of the management committee. R. Craig Collister and Timothy J. Connors are also managing partners. Damico and Knight remain identified as founding partners and senior advisors. The September 2026 appointment of Ed Jones as an operating partner supplemented the operating team rather than replacing the firm’s investment organization.

4. What Is the History of RoundTable Healthcare Partners?

RoundTable’s development is most clearly traced through successive fundraises, expansion of its operating resources, and healthcare platform investments. Six milestones explain the organization’s evolution without treating fundraising as evidence of investment performance.

  1. 2001 and 2002: formation and the first equity fund. The firm began in 2001 and closed its first equity fund in March 2002 with $400 million. This established the original combination of healthcare operating experience, industry relationships, and transaction expertise. The business’s founding and its first fund closing are separate events.
  2. 2006: a separate captive debt vehicle. RoundTable announced the closing of a $200 million subordinated debt fund on July 17, 2006. The vehicle was designed to invest alongside its equity funds, adding a dedicated financing resource for portfolio transactions rather than creating an unrelated corporate equity strategy.
  3. 2010: the third equity fund and second capital fund. The July 15, 2010 announcement disclosed a $600 million Equity Fund III and a $200 million Capital Fund II. It also documented an expanded partnership and operating organization.
  4. 2015 and 2016: further fund and operating-team development. Equity Fund IV closed with $650 million, alongside a third $200 million capital fund. The subsequent arrival of Thomas Kapfer and Pierre Fréchette in 2016 brought executives who had previously led RoundTable portfolio companies into the investment firm’s operating leadership.
  5. 2019 and 2022: Funds V and VI. Fund V closed with $700 million in capital commitments on July 2, 2019. Fund VI closed with $800 million on May 3, 2022. Timothy Connors joined as a managing partner after leading the former portfolio company Advantice Health.
  6. 2025 and 2026: realizations and continuing investment activity. RoundTable completed the sale of its Designs for Health minority stake on October 22, 2025. It acquired Colorescience in February 2026 and added operating partners Amardeep Kahlon in May and Ed Jones in September. These events show both portfolio turnover and continued development of operating resources.

5. What Investment Strategies Does RoundTable Healthcare Partners Pursue?

RoundTable’s central investment proposition is direct equity investment in healthcare companies that can benefit from operating support and industry relationships. Its historical criteria emphasized established, profitable businesses. The model is therefore better understood through acquisitions and business development than through an assumption that it principally finances pre-commercial startups. That distinction describes the documented investment approach, not an absolute exclusion rule for every future transaction.

The firm identifies founder-owned businesses, family companies, management teams, and corporate carve-outs as relevant partnership situations. It says existing owners frequently retain meaningful equity and that investments are typically structured with the same equity securities held by RoundTable and its partners. These are firm-described practices, not proof that every transaction has identical governance or shareholder economics.

Its transaction record demonstrates ownership flexibility. The June 2022 Polymedco transaction was explicitly a completed majority investment alongside the company’s founders. Conversely, the Designs for Health investment was a minority holding that RoundTable subsequently sold back to the company. The latter is evidence of minority equity experience, but does not establish a separately marketed growth equity or venture fund.

Platform construction and acquisition-led development also matter. The 2013 purchase of Santa Cruz Nutritionals established a gummy nutraceuticals platform within Fund III. Alongside equity ownership, the transaction included financing from a captive subordinated debt vehicle. This illustrates a distinction central to the firm’s structure: ownership capital and portfolio financing can come from different RoundTable-managed vehicles.

6. What Funds Does RoundTable Healthcare Partners Manage?

RoundTable’s publicly identifiable structure consists of successive healthcare equity funds and a separate series of captive subordinated debt funds. Its September 15, 2026 announcement reported $4.25 billion in cumulative committed capital raised, comprising six equity funds totaling $3.65 billion and three subordinated debt funds totaling $600 million. This is a fundraising measure, not a current assets-under-management, net asset value, or available-capital measurement.

  • Equity Fund I: $400 million; closed in March 2002.
  • Equity Fund II: $500 million; closed in March 2005.
  • Equity Fund III: $600 million; closed in July 2010.
  • Equity Fund IV: $650 million; closed in August 2015.
  • Equity Fund V: $700 million in capital commitments; closing announced July 2, 2019.
  • Equity Fund VI: $800 million in capital commitments; closing announced May 3, 2022.

These figures describe completed equity fundraises, not targets or interim fundraising amounts. Fund VI is the latest equity fund final close verified for this profile. The sequence does not establish that every predecessor fund remains in an investment period or continues to own its original portfolio.

The capital funds were separately raised: the first $200 million vehicle in 2006, the second $200 million vehicle in 2010, and the third $200 million vehicle in 2015. Their disclosed purpose was subordinated lending alongside equity investments. Transaction announcements identify Capital Fund III as a provider of acquisition financing, including for Polymedco. Such lending should not be mistaken for an additional equity ownership percentage.

7. What Types of Companies Does RoundTable Healthcare Partners Invest In?

The original investment criteria provide useful historical context. In March 2002, RoundTable described controlling equity investments of approximately $5 million to $50 million in companies with $25 million to $300 million in revenue. Those were launch-era criteria. They are not presented here as the firm’s current ticket range, enterprise-value range, or company eligibility requirements. A current firmwide numerical size framework has not been verified.

More recent transactions are more informative about business situations. Polymedco represents an established diagnostics business whose founders partnered with a majority investor. EHOB represents a family-founded medical products company with an operating organization and a defined hospital-use product range. These examples support an emphasis on existing businesses and owner partnerships rather than an inference that RoundTable’s model requires newly created companies without commercial operations.

Consumer health investments can have different commercial models. Colorescience sells skincare and sun protection products through professional channels, direct-to-consumer sales, and e-commerce platforms. Designs for Health developed and marketed supplements and functional foods for healthcare professionals and their patients. Neither business should be treated as equivalent to a medical device manufacturer simply because both sit within the healthcare investment scope.

Analytically, the common thread is an operating business with products, customers, and a development agenda that can use specialized resources. Company scale, ownership structure, regulatory exposure, and financing requirements still need transaction-specific assessment; historical investment ranges do not establish present-day suitability.

8. Which Industries Does RoundTable Healthcare Partners Focus On?

Medical devices and diagnostics are a substantive part of RoundTable’s investment history. Polymedco markets and distributes diagnostic tests, including products used for colorectal cancer screening and cardiac testing. EHOB manufactures and distributes pressure injury prevention and safe patient handling products. These investments involve different products and customers, but both depend on understanding clinical use and healthcare pur

Consumer health, OTC products, and nutraceuticals span branded products, professional recommendations, and manufacturing. Colorescience illustrates skincare and sun protection. Advantice Health represented branded OTC products, while Designs for Health represented practitioner-oriented supplements. These are distinct business models within a broad consumer health investment area, not interchangeable categories of hea

Contract development and manufacturing is also relevant. RoundTable’s documented portfolio history includes pharmaceutical manufacturing through Renaissance and nutraceutical manufacturing through Santa Cruz Nutritionals. Here, the operating proposition concerns supplying other healthcare businesses as well as developing products, rather than relying exclusively on o

The documented portfolio also includes DDS Lab, a dental laboratory, and Healthcare Components Group, a supplier of medical components and parts. These examples broaden the product and supply-chain exposure without establishing that RoundTable specializes in ow

9. Where Does RoundTable Healthcare Partners Invest?

RoundTable is headquartered in Lake Forest, Illinois, in the United States. Headquarters identifies the location of the investment organization. It does not mean the firm invests only in Illinois or that its portfolio compa

The reviewed transactions demonstrate investment activity across multiple United States markets. EHOB is based in Indianapolis, Indiana, and Polymedco in Cortlandt Manor, New York. Colorescience is headquartered in Carlsbad, California. The geographic dispersion of these companies supports a United States-centered investment footprint rathe

North America is the editorial geography group used for this profile. It is a regional classification supported by the firm’s location and reviewed investment examples, not a claim that every North American country receives equal investment attention. A comprehensive country-by-country mandate or current allocation schedule has not been verified.

Investment geography must also be distinguished from customer geography. Polymedco’s disclosure describes customers across North America, while Colorescience uses multiple commercial channels. A portfolio company’s distribution reach does not, by itself, establish that RoundTable has made direct investments in eve

10. How Does RoundTable Healthcare Partners Seek to Create Value?

RoundTable’s operating orientation is supported by identifiable specialist roles rather than only a general statement about helping management. Fouad Abou-Chakra, senior vice president of manufacturing, is described as providing oversight and guidance on manufacturing, global sourcing, quality, and supply chain. That role is relevant to businesses where product quality, production capacity, and reliable supply are central to execution. It does not establish a part

Matthew Kohut, senior vice president of commercial strategy and development, works with portfolio management teams on developing and executing market strategies. David O’Brien, senior vice president of human resources, provides counsel and resources for strategic human resources initiatives. These are executives employed by each portfoliohut.html))

Barbara Sullivan’s responsibilities include partnering with platform leadership teams on operating performance and leading organizational development for RoundTable. The team also identifies Bernadette Legarreta as an operating partner, chief financial officer, and chief compliance officer. At the capability level, the firm describes support for ERP and IT infrastructure, reporting, controls, product pipelines, and management-team devvan.html))

The 2026 additions of Amardeep Kahlon and Ed Jones expanded the operating-partner organization. Jones’s prior leadership of HealthTrust Performance Group brings healthcare purchasing and hospital-system experience. These appointments establish available expertise, not deployment at every company or a quantified portfolio-wide benefit. The appropriate interpretation is an operating resource model whose application and outcomes require company-specific ner.html))

11. What Types of Business Situations May Fit RoundTable Healthcare Partners?

The following situations are analytical interpretations of RoundTable’s documented transactions and capabilities. They are not investment eligibility rules, a statement of current investment appetite, or advice that a particular business should seek investment from the firm.

  • A founder or family seeking an operating partner. EHOB’s investment announcement emphasizes the relationship with its founder’s family and management. This is consistent with a transition in which ownership decisions and preservation of the business’s operating culture botent.html))
  • An established product business expanding its channels. Colorescience’s professional, direct-to-consumer, and e-commerce model illustrates a situation involving channel development and product-range expansion rather than only financial restrand.html))
  • A manufacturer needing deeper operational resources. The firm’s manufacturing role covers sourcing, quality, and supply chain, making those disciplines relevant when assessing a manufacturing-centered investment skra.html))
  • A healthcare corporate carve-out. RoundTable specifically identifies complex carve-outs among its capabilities. A separated business with operating and organizational development needs is therefore consistent with the firm-described approach, although no transaction’s suitability follows automout.html))

The recurring analytical consideration is whether the company’s development needs match the firm’s actual resources and sector experience. Ownership flexibility alone does not establish agreement on valuation, governance, financing, or a future business plan.

12. What Distinguishes RoundTable Healthcare Partners?

Five characteristics help distinguish RoundTable’s investment proposition without implying superior returns or suitability:

  • A concentrated healthcare scope. The firm’s investment identity remains healthcare-specific, while its portfolio spans devices, diagnostics, pharmaceuticals, supplements, skincare, and manufacturing. This is sector breadth within a focused industry, not a diversified private-marketslio.html))
  • Identifiable operating specialists. Manufacturing, commercial strategy, human resources, and organizational development are represented by named internal roles. Readers can therefore distinguish an operating-team model from a proposition based solely on capital pkra.html))
  • Experience on both sides of the ownership relationship. Kapfer, Fréchette, and Connors previously led RoundTable portfolio companies before joining the firm. Their backgrounds connect investment oversight with experience running businesses within its pfer.html))
  • Separate equity and captive financing vehicles. The capital-fund series supplies subordinated debt alongside equity investments. The distinction matters because financing exposure and corporate equity ownership are not the same relaund.html))
  • Partnership economics and ownership flexibility. RoundTable describes typically sharing the same equity securities with partners, while its transaction history includes both majority and minority investments. Neither feature means all deals have identicout.html))

13. How Should RoundTable Healthcare Partners Be Understood Today?

As of this profile’s October 13, 2026 review cutoff, RoundTable is best understood as an operating-oriented healthcare private equity firm with successive equity funds and complementary captive debt vehicles. The central proposition remains healthcare business development supported by operating and transaction expertise. Fund VI’s verified $800 million final close dates to May 3, 2022; it is not a new 2026 fundraising meaion.html))

The organization has continued to evolve through portfolio turnover and operating-team appointments. The completed Designs for Health stake sale in October 2025 contrasts with the Colorescience investment in February 2026. The additions of Amardeep Kahlon and Ed Jones during 2026 show continued investment in the operating-partner organization, without proving any particular portfolihip.html))

The $4.25 billion capital figure reported in September 2026 is cumulative committed capital raised across equity and subordinated debt funds. It should not be treated as current private equity AUM, remaining investment capacity, or a measure of returns. Similarly, a portfolio company’s Current classification does not imply unchanged ownership percentages or that every underlying holding was measured on the rev046.html))

Within the Umbrex research collection, the most useful descriptors are healthcare sector specialization, direct private equity and buyouts, ownership flexibility, and dedicated operating resources. Inclusion in the “Top 1000 Global Private Equity Firms” collection identifies the research scope, not a verified position in a ranking of size, prestige, or performance.

14. Frequently Asked Questions

Is RoundTable Healthcare Partners a private equity firm or a venture capital firm?

RoundTable describes itself as an operating-oriented healthcare private equity firm. Its documented approach includes acquisitions of established businesses and selected minority equity investments. Those activities do not establish a separately marketed venture capital und.html))

Who founded RoundTable Healthcare Partners?

The four founding partners were Joseph F. Damico, Lester B. Knight, Jack L. McGinley, and Todd E. Warnock. The firm began in 2001, while its first equity fund closed in Maund.html))

Where is RoundTable Healthcare Partners headquartered?

The firm is headquartered in Lake Forest, Illinois, United States. North America is its editorial geography group in this profile, while reviewed investments include companies based in California, Indiana, and eam.html))

What is RoundTable’s latest verified equity fund?

The latest verified equity fund final close is Fund VI, announced on May 3, 2022, with $800 million in capital commitments. That amount describes the fundraise, not current AUM, available capital, or investment perion.html))

Does RoundTable make minority investments?

Yes. Its investment in Designs for Health was a minority holding. RoundTable completed the sale of that stake back to the company on October 22, 2025, so Designs for Health is classified as Former in thiship.html))

What operating resources does RoundTable provide?

Documented internal roles cover manufacturing and supply chain, commercial strategy, human resources, finance, and organizational development. These establish available capabilities, but do not mean every portfolio company receives the same program or achieves the same kra.html))

Does inclusion in the Umbrex Top 1000 collection establish a ranking?

No. “Top 1000” identifies the research collection. Inclusion does not establish superior performance, fundraising strength, prestige, investment quality, current investment appetite, or suitability for a particular company.